Low-Dose Aspirin in the Primary Prevention of Cancer: The Women’s Health Study: A Randomized Controlled Trial

Cited by (796)

Items 101–200 of 796

  1. Comparison of physical activity assessed using hip- and wrist-worn accelerometers
    Masamitsu Kamada, Eric J. Shiroma, Tamara B. Harris, I-min M Lee · 2015 · Gait & Posture
  2. Alcohol Consumption, Weight Gain, and Risk of Becoming Overweight in Middle-aged and Older Women
    Wang, Lu · 2010 · Archives of Internal Medicine
  3. Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
    Ruth Elizabeth Langley, Sarah Burdett, Jayne F. Tierney, Fay Helen Cafferty, Mahesh Parmar, Geoffrey R Venning · 2011 · British Journal of Cancer
  4. Pancreatic Cancer: A Review of the Evidence on Causation
    Andrew R. Hart, Hugh J. Kennedy, Ian M. Harvey · 2008 · Clinical Gastroenterology and Hepatology
  5. Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
    U.S. Preventive Services Task Force* · 2007 · Annals of Internal Medicine
  6. Dietary Carotenoids, Vitamins C and E, and Risk of Cataract in Women
    William G. Christen · 2008 · Archives of Ophthalmology
  7. Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer
    Kimmie Ng, Jeffrey A. Meyerhardt, Andrew Tan Chan, Kaori Sato, Jennifer Ai-wen Chan, Donna Niedzwiecki, Leonard B. Saltz, Robert James Mayer, Al B. Benson, Paul Schaefer et al. · 2014 · JNCI Journal of the National Cancer Institute
  8. Dietary ω-3 Fatty Acid and Fish Intake and Incident Age-Related Macular Degeneration in Women
    Christen, William G. · 2011 · Archives of Ophthalmology
  9. Screening, Surveillance, and Primary Prevention for Colorectal Cancer: A Review of the Recent Literature
    Charles J. Kahi, Douglas Kevin Rex, Thomas F. Imperiale · 2008 · Gastroenterology
  10. Effects of Random Allocation to Vitamin E Supplementation on the Occurrence of Venous Thromboembolism
    Robert J. Glynn, Paul M. Ridker, Samuel Zachary Goldhaber, Robert Y.L. Zee, Julie E. Buring · 2007 · Circulation
  11. Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women
    Jennifer Lin, I-min M Lee, Nancy R. Cook, Jacob Selhub, JoAnn Elisabeth Manson, Julie E. Buring, Shumin M. Zhang · 2008 · American Journal of Clinical Nutrition
  12. Plasma Homocysteine and Cysteine and Risk of Breast Cancer in Women
    Jennifer Lin, I-min M Lee, Yiqing Song, Nancy R. Cook, Jacob Selhub, JoAnn Elisabeth Manson, Julie E. Buring, Shumin M. Zhang · 2010 · Cancer Research
  13. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies
    Elizabeth W. Karlson, Lori Beth Chibnik, Shelley S. Tworoger, I-min M Lee, Julie E. Buring, Nancy Ann Shadick, JoAnn Elisabeth Manson, Karen H. Costenbader · 2009 · Arthritis & Rheumatism
  14. Strength Training and the Risk of Type 2 Diabetes and Cardiovascular Disease
    Eric J. Shiroma, Nancy R. Cook, JoAnn Elisabeth Manson, Mv Moorthy, Julie E. Buring, Eric B. Rimm, I-min M Lee · 2016 · Medicine & Science in Sports & Exercise
  15. The role of cyclooxygenase-2 in breast cancer: review
    Gurpreet Singh‐Ranger, Mohamed Salhab, Kefah Mokbel · 2007 · Breast Cancer Research and Treatment
  16. Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: Characterization of interaction of NSAIDs with phosphatidylcholine
    Lenard M. Lichtenberger, Yong Zhou, Vasanthi Jayaraman, J. Rand Doyen, Roger G. O’Neil, Elizabeth J. Dial, David E. Volk, David G. Gorenstein, Mohan Babu Boggara, Ramanan Krishnamoorti · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  17. Fruit and Vegetable Intake and the Risk of Hypertension in Middle-Aged and Older Women
    L. Wang, JoAnn Elisabeth Manson, J. Michael Gaziano, Julie E. Buring, Howard D. Sesso · 2011 · American Journal of Hypertension
  18. Aspirin and antiplatelet treatments in cancer
    Derrick Law Tao, Samuel Tassi Yunga, Craig D. Williams, Owen J. T. McCarty · 2021 · Blood
  19. The Joint Effects of Physical Activity and Body Mass Index on Coronary Heart Disease Risk in Women
    Weinstein, Amy R., Sesso, Howard D., Lee, I-Min, Rexrode, Kathryn M., Cook, Nancy R., Manson, JoAnn E., Buring, Julie E., Gaziano, J. Michael · 2008 · Archives of Internal Medicine
  20. Complex roles of the old drug aspirin in cancer chemoprevention and therapy
    Hui Ming Hua, Hongying Zhang, Qingbin Kong, Jiao Wang, Yangfu Jiang · 2018 · Medicinal Research Reviews
  21. Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology
    Roy S. Herbst, Dean F. Bajorin, Harry Bleiberg, Diane Blum, Desirée Hao, Bruce Evan Johnson, Robert F. Ozols, George D. Demetri, Patricia A. Ganz, Mark G. Kris et al. · 2005 · Journal of Clinical Oncology
  22. Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk
    Patrick R. Lawler, Akintunde O. Akinkuolie, Paulette D. Chandler, M. Vinayaga Moorthy, Martin VanDenburgh, Debra Ann Schaumberg, I-min M Lee, Robert J. Glynn, Paul M. Ridker, Julie E. Buring et al. · 2016 · Circulation Research
  23. Aspirin and cancer risk: an updated quantitative review to 2005
    Cristina Bosetti, Silvano Gallus, Carlo La Vecchia · 2006 · Cancer Causes & Control
  24. Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention
    Susan M. Fischer, Ernest T. Hawk, Ronald A. Lubet · 2011 · Cancer Prevention Research
  25. A Prospective Study of Plasma Adiponectin and Pancreatic Cancer Risk in Five US Cohorts
    Ying Bao, Edward L. Giovannucci, Peter L. Kraft, Meir J. Stampfer, Shuji Ogino, Jing Ma, Julie E. Buring, Howard D. Sesso, I-min M Lee, J. Michael Gaziano et al. · 2012 · JNCI Journal of the National Cancer Institute
  26. Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway
    Dan Liao, Li Zhong, Tingmei Duan, Ru-Hua Zhang, Xin Wang, Gang Wang, Kaishun Hu, Xiaobin Lv, Tiebang Kang · 2015 · Clinical Cancer Research
  27. Genome-Wide Association Study of Relative Telomere Length
    Jennifer Prescott, Peter L. Kraft, Daniel I. Chasman, Sharon A. Savage, Lisa J. Mirabello, Sonja I. Berndt, Joel L. Weissfeld, Jiali Han, Richard B. Hayes, Stephen Jacob Chanock et al. · 2011 · PLoS ONE
  28. Aspirin use and the risk of cholangiocarcinoma‡
    Jonggi Choi, Hassan M. Ghoz, Thoetchai Bee Peeraphatdit, Esha Baichoo, Benyam D. Addissie, William Scott Harmsen, Terry M. Therneau, Janet E. Olson, Roongruedee Chaiteerakij, Lewis Rowland Roberts · 2016 · Hepatology
  29. Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong
    Kelvin K.F. Tsoi, Man-Wai Ho, Felix C.H. Chan, Joseph J.�Y. Sung · 2018 · International Journal of Cancer
  30. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study
    Aditya Bardia, Janet E. Olson, Celine M. Vachon, DeAnn Lazovich, Robert Alan Vierkant, Alice H. Wang, Paul J. Limburg, Kristin E. Anderson, James R. Cerhan · 2010 · Breast Cancer Research and Treatment
  31. The role of vitamin D in the prevention of late-life depression
    Olivia I. Okereke, Ankura Singh · 2016 · Journal of Affective Disorders
  32. Thigh-worn accelerometry for measuring movement and posture across the 24-hour cycle: a scoping review and expert statement
    Stevens, Matthew L, Gupta, Nidhi, Inan Eroglu, Elif, Crowley, Patrick Joseph, Eroglu, Barbaros, Bauman, Adrian, Granat, Malcolm, Straker, Leon, Palm, Peter, Stenholm, Sari et al. · 2020 · BMJ Open Sport & Exercise Medicine
  33. Platelets Effects on Tumor Growth
    Hadi Alphonse Goubran, Julie Stakiw, Mirjana Radosevic, Thierry Burnouf · 2014 · Seminars in Oncology
  34. Epidemiologic Methods in Physical Activity Studies
    I. Lee · 2008
  35. Lipoprotein(a), Hormone Replacement Therapy, and Risk of Future Cardiovascular Events
    Jacqueline Suk Danik, Nader Rifai, Julie E. Buring, Paul M. Ridker · 2008 · Journal of the American College of Cardiology
  36. Long-term Aspirin Use and Mortality in Women
    Andrew Tan Chan, JoAnn Elisabeth Manson, Diane Feskanich, Meir J. Stampfer, Graham A. Colditz, Charles S. Fuchs · 2007 · Archives of Internal Medicine
  37. Do Moderate‐Intensity and Vigorous‐Intensity Physical Activities Reduce Mortality Rates to the Same Extent?
    Eric J. Shiroma, Howard D. Sesso, M. Vinayaga Moorthy, Julie E. Buring, I-min M Lee · 2014 · Journal of the American Heart Association
  38. C-Reactive Protein and Breast Cancer: New Insights from Old Molecule
    Shilpa Balaji Asegaonkar, Balaji Narayan Asegaonkar, Unmesh Vidyadhar Takalkar, Suresh Hariram Advani, Anand Thorat · 2015 · International Journal of Breast Cancer
  39. COX-2 and PGE2-dependent immunomodulation in breast cancer
    Edward P. Chen, Emer M. Smyth · 2011 · Prostaglandins & Other Lipid Mediators
  40. Diet and cancer prevention: the roles of observation and experimentation
    Marı́a Elena Martı́nez, James Roger Marshall, Edward L. Giovannucci · 2008 · Nature reviews. Cancer
  41. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study
    Gretchen L. Gierach, James Vincent Lacey, Arthur G. Schatzkin, Michael Fred Leitzmann, Douglas A. Richesson, Albert R. Hollenbeck, Louise Annette Brinton · 2008 · Breast Cancer Research
  42. Reproducibility of Accelerometer-Assessed Physical Activity and Sedentary Time
    Keadle, Sarah Kozey, Shiroma, Eric J., Kamada, Masamitsu, Matthews, Charles E., Harris, Tamara B., Lee, I-Min · 2017 · American Journal of Preventive Medicine
  43. Discordance between circulating atherogenic cholesterol mass and lipoprotein particle concentration in relation to future coronary events in women
    Lawler, Patrick R, Akinkuolie, Akintunde O, Ridker, Paul M, Sniderman, Allan D, Buring, Julie E, Glynn, Robert J, Chasman, Daniel I, Mora, Samia · 2017 · Clinical Chemistry
  44. Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer
    Brian Matthew Wolpin, Kimmie Ng, Ying Bao, Peter L. Kraft, Meir J. Stampfer, Dominique S. Michaud, Jing Ma, Julie E. Buring, Howard D. Sesso, I-min M Lee et al. · 2012 · Cancer Epidemiology Biomarkers & Prevention
  45. Low dose aspirin and cognitive function in the women's health study cognitive cohort
    Kang, Jae Hee, Cook, Nancy, Manson, JoAnn, Buring, Julie E, Grodstein, Francine · 2007 · BMJ
  46. Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms
    Whay Kuang Chia, Raghib Ali, Han Chong Toh · 2012 · Nature Reviews Clinical Oncology
  47. NSAIDs and breast cancer recurrence in a prospective cohort study
    Marilyn L. Kwan, Laurel A. Habel, Martha L. Slattery, Bette Jane Caan · 2007 · Cancer Causes & Control
  48. Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Cancer
    Shelley S. Tworoger, I-min M Lee, Julie E. Buring, BERNARD A. ROSNER, Bruce W. Hollis, Susan E. Hankinson · 2007 · Cancer Epidemiology Biomarkers & Prevention
  49. Role of Aspirin in Cancer Prevention
    Mangesh A. Thorat, Jack M. Cuzick · 2013 · Current Oncology Reports
  50. Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis
    Yashuang Zhao, Sui Zhu, Xiangwei Li, Fan Wang, Fulan Hu, Dandan Li, Wencui Zhang, Xia Li · 2008 · Breast Cancer Research and Treatment
  51. Considerations for Pharmacoepidemiological Studies of Drug–Cancer Associations
    Anton Pottegård, Søren Friis, Til Stürmer, Jesper Hallas, Shahram Bahmanyar · 2017 · Basic & Clinical Pharmacology & Toxicology
  52. Body Mass Index, Migraine, Migraine Frequency and Migraine Features in Women
    Anke C. Winter, Klaus Berger, Julie E. Buring, Tobias Kurth · 2008 · Cephalalgia
  53. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews
    Paul A Sutcliffe, Martin J Connock, Tara Gurung, Karoline Freeman, Samantha Ann Johnson, Ngianga‐Bakwin Kandala, Amy Grove, Binu Gurung, Sarah Morrow, Aileen Clarke · 2013 · Health Technology Assessment
  54. Opportunities and Strategies for Breast Cancer Prevention Through Risk Reduction
    M. C. Mahoney, T.B. Bevers, Eleni Linos, Walter Churchill Willett · 2008 · CA A Cancer Journal for Clinicians
  55. Chemoprevention of Colorectal Neoplasia: The Potential for Personalized Medicine
    Nadir Arber, Bernard Levin · 2008 · Gastroenterology
  56. C-Reactive Protein and Risk of Breast Cancer
    S. M. Zhang, Jennifer Lin, Nancy R. Cook, I-min M Lee, JoAnn Elisabeth Manson, Julie E. Buring, Paul M. Ridker · 2007 · JNCI Journal of the National Cancer Institute
  57. Risks and Benefits of Celecoxib to Prevent Recurrent Adenomas
    Bruce M. Psaty, John D. Potter · 2006 · New England Journal of Medicine
  58. Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent
    Melania Dovizio, Stefania Tacconelli, Carlos Sostres, Emanuela Ricciotti, Paola Patrignani · 2012 · Pharmaceuticals
  59. In vitro anti inflammatory activity of Aloe vera by down regulation of MMP-9 in peripheral blood mononuclear cells
    Damodharan Vijayalakshmi, Dhandapani Ramamurthy, Sivalingam Jayaveni, Jithendra Panneerselvam, Chellan Rose, Asit Baran Mandal · 2012 · Journal of Ethnopharmacology
  60. Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women
    Lu Wang, JoAnn E. Manson, John P. Forman, J. Michael Gaziano, Julie E. Buring, Howard D. Sesso · 2010 · Hypertension
  61. Associations of plasma carotenoids with risk factors and biomarkers related to cardiovascular disease in middle-aged and older women
    Wang, Lu, Gaziano, J Michael, Norkus, Edward P, Buring, Julie E, Sesso, Howard D · 2008 · The American Journal of Clinical Nutrition
  62. Strength Training and All‐Cause, Cardiovascular Disease, and Cancer Mortality in Older Women: A Cohort Study
    Masamitsu Kamada, Eric J. Shiroma, Julie E. Buring, Motohiko Miyachi, I-min M Lee · 2017 · Journal of the American Heart Association
  63. Molecular cancer prevention: Current status and future directions
    Karen Colbert Maresso, Kenneth Yee Tsai, Powel H. Brown, Eva M. Szabo, Scott Michael Lippman, Ernest T. Hawk · 2015 · CA A Cancer Journal for Clinicians
  64. The Associations of Aspirin, Statins, and Metformin With Lung Cancer Risk and Related Mortality: A Time-Dependent Analysis of Population-Based Nationally Representative Data
    Jihun Kang, Su‐Min Jeong, Dong Wook Shin, Mi Hee Cho, Jong Ho Cho, Jehun Kim · 2020 · Journal of Thoracic Oncology
  65. Aspirin in the Prevention of Colorectal Neoplasia
    David A. Drew, Andrew Tan Chan · 2020 · Annual Review of Medicine
  66. A Prospective Study of Circulating C-Reactive Protein, Interleukin-6, and Tumor Necrosis Factor α Receptor 2 Levels and Risk of Ovarian Cancer
    Elizabeth M. Poole, I-min M Lee, Paul M. Ridker, Julie E. Buring, Susan E. Hankinson, Shelley S. Tworoger · 2013 · American Journal of Epidemiology
  67. Chemoprevention of colorectal cancer: Past, present, and future
    Shotaro Umezawa, Takuma Higurashi, Yasuhiko Komiya, Jun Arimoto, Nobuyuki Horita, Takeshi Kaneko, Motoki Iwasaki, Hitoshi Nakagama, Atsushi Nakajima · 2019 · Cancer Science
  68. Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer
    Elham Rahme, Joumana Ghosn, Kaberi Dasgupta, Raghu Rajan, Marie Hudson · 2005 · BMC Cancer
  69. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial
    Robert Benamouzig, Bernard Uzzan, Jacques Deyra, Antoine Martin, Bernard Girard, Julian Little, Stanislas Chaussade · 2011 · Gut
  70. Daily Aspirin Use and Cancer Mortality in a Large US Cohort
    Eric J. Jacobs, Christina C. Newton, Susan M. Gapstur, Michael J. Thun · 2012 · JNCI Journal of the National Cancer Institute
  71. Aspirin, cyclooxygenase inhibition and colorectal cancer
    Carlos Sostres · 2014 · World Journal of Gastrointestinal Pharmacology and Therapeutics
  72. Prevention Strategies in Endometrial Carcinoma
    Michelle Louise MacKintosh, Emma Jayne Crosbie · 2018 · Current Oncology Reports
  73. Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin
    Charles Mel Wilcox, Jeroan J. Allison, Keith H. Benzuly, Marie L. Borum, Byron Cryer, Tilo Großer, Richard H. Hunt, Uri Ladabaum, Ángel Lanas, Harold E. Paulus · 2006 · Clinical Gastroenterology and Hepatology
  74. AMPK: mediating the metabolic effects of salicylate-based drugs?
    Gregory R. Steinberg, Madhumita Dandapani, David Grahame Hardie · 2013 · Trends in Endocrinology and Metabolism
  75. Generalizability of the Results of Randomized Trials
    Noel S. Weiss · 2008 · Archives of Internal Medicine
  76. Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence
    Sarah Crawford · 2014 · Therapeutic Advances in Medical Oncology
  77. Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events
    Samia Mora, Nader Rifai, Julie E. Buring, Paul M. Ridker · 2006 · Circulation
  78. Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention
    Asad Umar, Vernon E. Steele, David G. Menter, Ernest T. Hawk · 2015 · Seminars in Oncology
  79. Association of Aspirin and Nonaspirin Nonsteroidal Anti-inflammatory Drugs With Cancer Incidence and Mortality
    Aditya Bardia, Jon O. Ebbert, Robert Alan Vierkant, Paul J. Limburg, K. Anderson, A. H. Wang, Janet E. Olson, CM Vachon, James R. Cerhan · 2007 · JNCI Journal of the National Cancer Institute
  80. Individual and joint use of statins and low‐dose aspirin and risk of colorectal cancer: A population‐based case–control study
    Michael Hoffmeister, Jenny C. Chang-Claude, Hermann Brenner · 2007 · International Journal of Cancer
  81. Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention
    Jadwiga Maniewska, Dagmara Jeżewska · 2021 · Cancers
  82. Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)‐style diet with risks of cardiovascular disease and venous thromboembolism
    Kathryn C. Fitzgerald, Stephanie E. Chiuve, Julie E. Buring, Paul M. Ridker, Robert J. Glynn · 2011 · Journal of Thrombosis and Haemostasis
  83. Aspirin, Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and Pancreatic Cancer Risk: a Clinic-Based Case–Control Study
    Xiang‐Lin Tan, Kaye M. Reid Lombardo, William R. Bamlet, Ann L. Oberg, Dennis P. Robinson, Kristin E. Anderson, Gloria M. Petersen · 2011 · Cancer Prevention Research
  84. Identifying an optimal cutpoint for the diagnosis of hypertriglyceridemia in the nonfasting state
    White, Khendi T, Moorthy, M V, Akinkuolie, Akintunde O, Demler, Olga, Ridker, Paul M, Cook, Nancy R, Mora, Samia · 2015 · Clinical Chemistry
  85. Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis
    María de Pedro, Sara Baeza, María-Teresa Escudero, Trinidad Dierssen‐Sotos, Inés Gómez‐Acebo, Marina Pollán, Javier Llorca · 2015 · Breast Cancer Research and Treatment
  86. Chemoprevention of Colorectal Cancer
    Debasish Das, Nadir Arber, Janusz A. Jankowski · 2007 · Digestion
  87. Dietary factors and cancer chemoprevention
    NS Murthy, S Mukherjee, Gautam Ray, A Ray · 2009 · Journal of Postgraduate Medicine
  88. Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women
    Christina S. Gamba, Susan M. Swetter, Marcia L. Stefanick, Jessica T. Kubo, Manisha Desai, Katrina M. Spaunhurst, Animesh A. Sinha, Maryam M. Asgari, Susan R. Sturgeon, Jean Yuh Tang · 2013 · Cancer
  89. Aspirin and Nonsteroidal Anti-Inflammatory Drugs Can Prevent Cutaneous Squamous Cell Carcinoma: a Systematic Review and Meta-Analysis
    Chiho Muranushi, Catherine M. Olsen, Nirmala Pandeya, Adèle C. Green · 2014 · Journal of Investigative Dermatology
  90. Aspirin and Colorectal Cancer: Back to the Future
    David Tougeron, Dan Sha, Sashidhar Manthravadi, Frank A. Sinicrope · 2013 · Clinical Cancer Research
  91. Nonsteroidal Antiinflammatory Drugs and Bladder Cancer: A Pooled Analysis
    Sarah E. Daugherty, Ruth M. Pfeiffer, Alice J. Sigurdson, Richard B. Hayes, M. Leitzmann, Arthur G. Schatzkin, A. R. Hollenbeck, Debra T. Silverman · 2011 · American Journal of Epidemiology
  92. The failure of cancer chemoprevention
    John D. Potter · 2014 · Carcinogenesis
  93. Emerging and multifaceted role of neutrophils in lung cancer
    Christian Anthony Aloe, Hao Wang, Ross Vlahos, Louis B. Irving, Daniel Steinfort, Steven Bozinovski · 2021 · Translational Lung Cancer Research
  94. Aspirin, nonsteroidal anti‐inflammatory drugs, paracetamol and risk of endometrial cancer: A case–control study, systematic review and meta‐analysis
    Annette S. Neill, Christina M. Nagle, Melinda M. Protani, Andreas Obermair, Amanda B. Spurdle, Penelope M. Webb, Georgia Chenevix‐Trench · 2012 · International Journal of Cancer
  95. Aspirin use and breast cancer risk: a meta-analysis
    Ting Luo, Huamei Yan, Ping He, Yong Luo, Yuan-Fu Yang, Hong Yu Zheng · 2011 · Breast Cancer Research and Treatment
  96. Case–Control Study of Aspirin Use and Risk of Pancreatic Cancer
    Samantha A. Streicher, Herbert Yu, Lingeng Lu, Mark S. Kidd, Harvey A. Risch · 2014 · Cancer Epidemiology Biomarkers & Prevention
  97. Anti-inflammatory drugs, antioxidants, and prostate cancer prevention
    Aditya Bardia, Elizabeth A. Platz, Srinivasan Yegnasubramanian, Angelo Michael De Marzo, William G. Nelson · 2009 · Current Opinion in Pharmacology
  98. Effect of Low-Dose Aspirin on the Occurrence of Venous Thromboembolism
    Robert J. Glynn, Paul M. Ridker, Samuel Zachary Goldhaber, Julie E. Buring · 2007 · Annals of Internal Medicine
  99. Aspirin Has A Gender-Dependent Impact on Antiinflammatory 15-Epi-Lipoxin A 4 Formation
    Nan Chiang, Shelley Hurwitz, Paul M. Ridker, Charles Nicholas Serhan · 2005 · Arteriosclerosis Thrombosis and Vascular Biology
  100. Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint
    Janusz A. Jankowski, Richard Hunt · 2008 · Cancer Epidemiology Biomarkers & Prevention